RecallDepth
Class I Terminated

Adrucil (fluorouracil injection, USP) Pharmacy Bulk Package Not for Direct Infusion, 5 g/100 mL (50 mg/mL), For Intravenous Use Only, Rx Only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-3019-11

Company
Teva Pharmaceuticals Usa
Recall Initiated
April 28, 2015
Posted
July 15, 2015
Recall Number
D-1089-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6195 vials
Firm Location
Horsham, PA, United States

Reason for Recall

Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.

Distribution

Nationwide

Lot / Code Info

Lot #s: 31317858B, Exp 11/2015; 31317899B, 31317906B, 31317958B, 31317959B, 31318103B, 31318137B, Exp 12/2015; 31318533B, Exp 07/2016

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class I Drug recalls